Blueface, Emutex to help SMEs cut costs with ‘office in a box’
7 March 2011 | 0
Internet telephony provider Blueface has announced a new cost-saving product for SMEs, Emutex VMX.
VMX is engineered in Ireland by Limerick-based Emutex. Labelled as ‘an office in a box’, VMX offers a complete set of modern business phone features and enables SMEs to benefit from the low cost phone call charges offered by Blueface’s rapidly expanding VoIP service.
Tipperary based insurance company, Cullen Insurance, has recently signed up to the service.
Prior to signing up to the Blueface offering, Cullen Insurance used a traditional phone system from another leading Irish telecoms company. The system consisted of a PBX and 12 proprietary digital phones, and required numerous ISDN and analogue lines to facilitate phone calls. Though the system functioned well the monthly phone bills were very high, driven by the recurring line rental costs and the call charges accrued by the thousands of calls made by the Cullen Insurance team each month.
Doug Howell, Cullen Insurance, commented: “SMEs really need to think about their bottom line and implement cost -saving strategies where possible. With this new service from Blueface, we are delighted to be in a position to save our company several thousands of euro each year, and we are already reaping the benefits. The numbers of incoming phone calls have increased; more calls are being answered; sales have increased; and our phone bills have been reduced, all thanks to this efficient service.”
Alan Foy, CEO, Blueface, commented: “We are offering SME’s the opportunity to significantly cut their telecoms costs with the Emutex VMX solution… Our service is tailored to the cost and service needs of individual businesses, with this solution business customers can pay monthly per user for the hardware or upfront costs. Cullen Insurance is only one example of an SME that will make substantial savings on their monthly bills this year.”
Pictured (l-r) Alan Foy, CEO, Blueface; Doug Howell, MD Cullen Insurances; John Twomey, MD Emutex